Skip to main content
Top
Published in:

28-09-2024 | ASO Visual Abstract

ASO Visual Abstract: miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer

Authors: Hiroki Ueda, MD, Hidenori Takahashi, MD, PhD, Shogo Kobayashi, MD, PhD, Masahiko Kubo, MD, PhD, Kazuki Sasaki, MD, PhD, Yoshifumi Iwagami, MD, PhD, Daisaku Yamada, MD, PhD, Yoshito Tomimaru, MD, PhD, Tadafumi Asaoka, MD, PhD, Takehiro Noda, MD, PhD, Junzo Shimizu, MD, PhD, Yuichiro Doki, MD, PhD, Hidetoshi Eguchi, MD, PhD

Published in: Annals of Surgical Oncology | Issue 2/2025

Login to get access
Metadata
Title
ASO Visual Abstract: miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer
Authors
Hiroki Ueda, MD
Hidenori Takahashi, MD, PhD
Shogo Kobayashi, MD, PhD
Masahiko Kubo, MD, PhD
Kazuki Sasaki, MD, PhD
Yoshifumi Iwagami, MD, PhD
Daisaku Yamada, MD, PhD
Yoshito Tomimaru, MD, PhD
Tadafumi Asaoka, MD, PhD
Takehiro Noda, MD, PhD
Junzo Shimizu, MD, PhD
Yuichiro Doki, MD, PhD
Hidetoshi Eguchi, MD, PhD
Publication date
28-09-2024
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2025
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-024-16268-8
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

  • Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now